Biggest Seed, Series A-E and Venture Investments within Oncology February 2024.
View the report at the bottom of this page.
February 2024 Snapshot:
152 Companies across EU and US were involved in some sort of cash movements (all indications, all cash types). From this $ 15,424,100,098.00 total true investment received in USA and EU within the Oncology sector in February 2024 across 33 different biotechs.
Some Notable True Oncology Investments
✅NextPoint Therapeutics - $42,500,000 (Series B): 2x Phase I for oncology trials
✅Athos Therapeutics - $ 35,000,000 (Series B): AI-based precision small molecules for autoimmune diseases and various cancer indications
✅Frontier Medicines - (Series C): multiple wholly owned precision programs including lead program novel inhibitor in Phase I trial
✅ Plus 30+ companies in the report.
Click here to view full report.
